Search
Procept Biorobotics Corp
PRCTAdd to Watchlist
26.190USD
+0.490+1.91%
Market hours （ET）Quotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM
More Details of Procept Biorobotics Corp Company
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Procept Biorobotics Corp Info
Ticker SymbolPRCT
Company nameProcept Biorobotics Corp
IPO dateSep 15, 2021
CEOWood (Larry L)
Number of employees756
Security typeOrdinary Share
Fiscal year-endSep 15
Address150 Baytech Drive
CitySAN JOSE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code95134
Phone16502329832
Websitehttps://www.procept-biorobotics.com/
Ticker SymbolPRCT
IPO dateSep 15, 2021
CEOWood (Larry L)
Company Executives of Procept Biorobotics Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
861.62K
-0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
132.71K
-1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.68K
-38.27%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
12.85K
-11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
786.00
-395.67%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
861.62K
-0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
132.71K
-1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.68K
-38.27%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
12.85K
-11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Hand pieces and other consumables
181.45M
58.90%
System sales and rentals
106.13M
34.45%
Service
20.48M
6.65%
By RegionUSD
Name
Revenue
Proportion
United States
270.38M
87.77%
Outside United States
37.68M
12.23%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Hand pieces and other consumables
181.45M
58.90%
System sales and rentals
106.13M
34.45%
Service
20.48M
6.65%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
8.10%
BlackRock Institutional Trust Company, N.A.
6.66%
AllianceBernstein L.P.
5.95%
T. Rowe Price Investment Management, Inc.
5.75%
Vanguard Portfolio Management, LLC
4.25%
Other
69.29%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
8.10%
BlackRock Institutional Trust Company, N.A.
6.66%
AllianceBernstein L.P.
5.95%
T. Rowe Price Investment Management, Inc.
5.75%
Vanguard Portfolio Management, LLC
4.25%
Other
69.29%
Shareholder Types
Shareholders
Proportion
Investment Advisor
62.23%
Investment Advisor/Hedge Fund
27.95%
Hedge Fund
8.01%
Research Firm
3.63%
Individual Investor
3.13%
Pension Fund
1.16%
Bank and Trust
1.00%
Venture Capital
0.84%
Sovereign Wealth Fund
0.15%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
597
65.01M
114.22%
-1.01M
2025Q4
573
59.92M
107.23%
-2.03M
2025Q3
536
55.75M
99.78%
-1.67M
2025Q2
535
55.45M
100.20%
-990.27K
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.61M
8.18%
-3.28M
-41.57%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
6.72%
+62.83K
+1.69%
Dec 31, 2025
AllianceBernstein L.P.
3.39M
6%
-34.36K
-1.00%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
3.27M
5.8%
+1.22M
+59.38%
Dec 31, 2025
Chicago Capital, LLC
1.19M
2.11%
-377.85K
-24.08%
Dec 31, 2025
BNP Paribas Asset Management USA, Inc.
1.85M
3.28%
+757.43K
+69.38%
Dec 31, 2025
Mackenzie Financial Corporation
1.57M
2.79%
+118.97K
+8.18%
Dec 31, 2025
State Street Investment Management (US)
1.49M
2.64%
+164.36K
+12.41%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
1.64%
State Street SPDR S&P Health Care Equipment ETF
1.62%
ALPS Disruptive Technologies ETF
0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.7%
Global X Robotics & Artificial Intelligence ETF
0.7%
Main Thematic Innovation ETF
0.46%
Harbor Health Care ETF
0.35%
Langar Global HealthTech ETF
0.32%
iShares U.S. Medical Devices ETF
0.22%
Nuveen ESG Small-Cap ETF
0.17%
View more
Global X HealthTech ETF
Proportion1.64%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.62%
ALPS Disruptive Technologies ETF
Proportion0.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.7%
Global X Robotics & Artificial Intelligence ETF
Proportion0.7%
Main Thematic Innovation ETF
Proportion0.46%
Harbor Health Care ETF
Proportion0.35%
Langar Global HealthTech ETF
Proportion0.32%
iShares U.S. Medical Devices ETF
Proportion0.22%
Nuveen ESG Small-Cap ETF
Proportion0.17%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
